Tag: cannabinoid pharmaceutical R&D
AusCann raises A$33.4m via share placementÂ
ASX-listed medical marijuana company AusCann has successfully raised A$33.4 million via a share placement to institutional and sophisticated investors from North America and Australia, including...
Featured Article
Reality check: Aussie factories’ journey to responsible AI implementation
Artificial intelligence has become more than just a buzzword as it promises to revolutionise every other industry in the world, including manufacturing. In Australia, in particular, the hype surrounding AI and automation has reached a fever pitch, with many business leaders leveraging their resources to race towards adoption and implementation.
